fda shortage tirzepatide update off the list What Is Tirzepatide Used for? Approved and Potential Uses Important Notice: Tirzepatide Compounding Update

The Synergy of Dual Agonism What sets Tirzepatide apart in current research is its ability to mimic two endogenous hormones rather than just one

Mounjaro (Tirzepatide) Injection 7.5 mg/0.5 mL Prefilled Syringes are a type of medication used to treat type 2 diabetes. They contain the active ingredient tirzepatide, which belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. This medication is delivered as a pre-filled syringe that contains 7.5 mg of tirzepatide in a solution of 0.5 mL. It is given as a subcutaneous injection (under the skin) once a week and works by mimicking the function of a naturally occurring hormone in the body called GLP-1, which helps regulate blood sugar levels. Mounjaro is intended to be used in conjunction with a healthy diet and exercise to help control blood sugar in adults with type 2 diabetes. It may also help in weight management for people with obesity or overweight. As with any medication, it is important to follow the instructions of a healthcare professional and to report any side effects experienced

Common adverse effects include gastrointestinal symptomsnausea, vomiting, diarrhea, and constipationwhich typically diminish with continued use

Mounjaros effect on human fertility is unknown

This LOE discount creates acquisition opportunities